To this end, approximately 5% of CD4+ T cells in most COVID-19 cases are specific for ORF8 protein, and ORF8 protein accounts for 10% of CD8+ T cell reactivity in COVID-19 recovered subjects [87, 88]. The gene discussed is CD8A; the disease is COVID-19.